THERASENSE INC 4
4 · THERASENSE INC · Filed Apr 6, 2004
Insider Transaction Report
Form 4
THERASENSE INCTHER
KULP HOLLY D
VP of CS and PR
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$18.00/sh−29,820$536,760→ 0 totalExercise: $9.00From: 1988-08-08Exp: 2011-08-03→ Common Stock (29,820 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$22.00/sh−13,947$306,834→ 0 totalExercise: $5.00From: 1988-08-08Exp: 2010-09-29→ Common Stock (13,947 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$24.00/sh−2,397$57,528→ 0 totalExercise: $3.00From: 1988-08-08Exp: 2010-03-17→ Common Stock (2,397 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−5,016$135,432→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$19.91/sh−10,000$199,100→ 0 totalExercise: $7.09From: 1988-08-08Exp: 2013-02-25→ Common Stock (10,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.00/sh−8,711$200,353→ 0 totalExercise: $4.00From: 1988-08-08Exp: 2010-07-31→ Common Stock (8,711 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.80/sh−22,326$151,817→ 0 totalExercise: $20.20From: 1988-08-08Exp: 2014-01-05→ Common Stock (22,326 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$3.20/sh−20,000$64,000→ 0 totalExercise: $23.80From: 1988-08-08Exp: 2011-12-14→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$26.50/sh−2,659$70,464→ 0 totalExercise: $0.50From: 1988-08-08Exp: 2009-01-05→ Common Stock (2,659 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F2]This option provided for vesting over a four year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F3]Includes 1,769 shares acquired under the TheraSense, Inc. Employee Stock Purchase Plan on April 2, 2004.